Low molecular weight heparin prophylaxis to prevent VTE events in hospitalized oncology patients.
Low molecular weight heparin is a well-supported prophylactic option to effectively reduce the risk of VTE events in hospitalized oncology patients, with guidelines endorsing its use during hospital stays.
Authors
- Tripdatabase
Publication Details
- Journal
- Zenodo (CERN European Organization for Nuclear Research)
- Published
- 2026-11-18
- DOI
- https://doi.org/10.5281/zenodo.24344982
- Primary Topic
- Venous Thromboembolism Diagnosis and Management
- Type
- article
- Field-Weighted Citation Impact
- 0.00